Duration of Cefixime in Enteric Fever
For enteric fever (typhoid), cefixime should be administered for 7-10 days at a dose of 15 mg/kg twice daily (maximum 400 mg/day), though current evidence suggests cefixime is NOT a preferred first-line agent due to inferior efficacy compared to alternatives.
Critical Context: Cefixime's Declining Role
The evidence reveals a significant problem with cefixime for enteric fever treatment. A high-quality randomized trial demonstrated that cefixime had a 37.6% treatment failure rate compared to only 3.5% with gatifloxacin 1. This dramatic difference led to early trial termination by the safety monitoring board. The median fever clearance time was 138 hours with cefixime versus 92 hours with gatifloxacin 1.
Recommended Treatment Duration When Cefixime Must Be Used
Standard Dosing Protocol
- Duration: 7-10 days minimum 2
- Adult dose: 400 mg once daily 3
- Pediatric dose: 20 mg/kg/day in two divided doses (maximum 400 mg/day) 2
- Alternative pediatric regimen: 16 mg/kg/day for 14 days showed clinical cure rates of 71% 4
When to Extend Beyond 7 Days
The WHO guideline recommends cefixime as a second-line option for multidrug-resistant strains 5, but clinical data suggests:
- Minimum 12 days may be needed for adequate response 6
- One study using 14-day courses showed better outcomes 4
- Treatment should continue until clinical resolution is achieved
Preferred Alternatives (Better Efficacy)
Current evidence strongly favors these options over cefixime:
First-Line Choices
Ceftriaxone (IV): 80 mg/kg/day for 5-7 days 2, 5
- Superior to cefixime in head-to-head trials 1
- Preferred for severe cases
Ciprofloxacin: 15 mg/kg twice daily for 7-10 days 2, 5
- Only in areas without quinolone resistance
Critical Clinical Pitfalls
Why Cefixime Often Fails
- Inadequate bactericidal levels: Oral cefixime achieves lower and less sustained blood levels than parenteral ceftriaxone 7
- High treatment failure rates: 27% acute clinical failure in controlled trials 1
- Slower clinical response: Significantly longer fever clearance times 4, 1
Resistance Considerations
- Cefixime is recommended only for multidrug-resistant strains (resistant to chloramphenicol, ampicillin, trimethoprim-sulfamethoxazole) 5
- In regions with extensively drug-resistant (XDR) typhoid, cefixime may be completely ineffective
- 88.7% of isolates in one study were MDR, and 93.5% were nalidixic acid-resistant 4
Practical Treatment Algorithm
Step 1: Assess local resistance patterns
- If quinolone-sensitive → Use ciprofloxacin or gatifloxacin
- If quinolone-resistant but cephalosporin-sensitive → Consider azithromycin first
Step 2: If cefixime must be used (limited alternatives):
- Start 400 mg daily (adults) or 20 mg/kg/day divided (children)
- Plan for minimum 7-10 days
- Monitor fever clearance closely
Step 3: Assess response at 72-96 hours
- If fever persists beyond 5 days → Switch to azithromycin or ceftriaxone
- If clinical deterioration → Switch immediately to IV ceftriaxone
Step 4: Complete full course
- Minimum 7 days if excellent response
- Extend to 10-14 days if slow response
- Follow-up at 8 weeks to detect relapse (2-4% risk) 6
Combination Therapy (Emerging Strategy)
Azithromycin + cefixime combination is under investigation 8 based on the rationale that:
- Azithromycin targets intracellular bacteria
- Cefixime targets extracellular bacteria
- Combination may prevent resistance emergence
However, this remains experimental and is not yet standard practice.
Key Monitoring Parameters
- Fever clearance time: Should occur within 5-7 days
- Clinical improvement: Appetite return, reduced abdominal pain
- Warning signs of failure: Persistent fever >7 days, worsening symptoms, complications (perforation, bleeding)
- Relapse surveillance: Follow-up at 4-8 weeks post-treatment